Remi Barbier's Insider Trades & SAST Disclosures
Remi Barbier's most recent trade in Cassava Sciences Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Remi Barbier.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cassava Sciences Inc | Remi Barbier | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 71,428 | 0 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 24 May 2023 | 71,428 | 782,002 (4%) | 0% | 16.9 | 1,204,990 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.25 per share. | 24 May 2023 | 47,723 | 734,279 (4%) | 0% | 25.3 | 1,205,006 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 14,285 | 0 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 24 May 2023 | 14,285 | 390,397 (2%) | 0% | 16.9 | 240,988 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.25 per share. | 24 May 2023 | 9,545 | 380,852 (2%) | 0% | 25.2 | 241,011 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2022 | 57,143 | 710,574 (4%) | 0% | 0 | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.38 per share. | 06 Jun 2022 | 65,368 | 822,437 (4%) | 0% | 23.4 | 1,528,304 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 65,368 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.93 per share. | 06 Jun 2022 | 54,720 | 767,717 (4%) | 0% | 27.9 | 1,528,330 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 44,791 | 5,209 | - | - | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. | 25 Apr 2022 | 44,791 | 371,443 (2%) | 0% | 0.9 | 42,551 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 25 Apr 2022 | 4,669 | 376,112 (2%) | 0% | 16.3 | 76,151 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 4,669 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2021 | 2,801 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.23 per share. | 20 Jul 2021 | 2,801 | 326,652 (1%) | 0% | 20.2 | 56,664 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 56,030 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.55 per share. | 27 May 2021 | 56,030 | 1,134,885 (6%) | 0% | 53.6 | 3,000,407 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.60 per share. | 27 May 2021 | 53,965 | 1,080,920 (6%) | 0% | 55.6 | 3,000,454 | Common Stock |
| Cassava Sciences Inc | Remi Barbier | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.59 per share. | 24 Sep 2020 | 10,000 | 1,078,855 (6%) | 0% | 9.6 | 95,900 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges